JULIA MCVAY: Open Payments
NPI 1508490392 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,381 in 75 payments from 14 companies in 2025. Trend: 2023 $1,027 · 2024 $1,282 · 2025 $1,381
Food & beverage: $1,381
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $210 |
| Vanda Pharmaceuticals Inc. | 7 | $195 |
| Corium, LLC | 9 | $155 |
| Teva Pharmaceuticals USA, Inc. | 11 | $154 |
| Supernus Pharmaceuticals, Inc. | 7 | $122 |
| Otsuka America Pharmaceutical, Inc. | 5 | $102 |
| Axsome Therapeutics, Inc. | 5 | $92 |
| Alkermes, Inc. | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Lundbeck LLC | 3 | $63 |
Products named: CAPLYTA, Azstarys, HETLIOZ, REXULTI, Qelbree, Auvelity, UZEDY, ARISTADA.
Industry payments across KS — which companies pay providers there.
